N-Nitroso Edoxaban Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Edoxaban is used to prevent stroke and blood clots in patients with a certain heart rhythm problem (eg, nonvalvular atrial fibrillation). Edoxaban is also used to treat deep venous thrombosis, a condition in which harmful blood clots form in the blood vessels of the legs.N-Nitroso Edoxaban Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Edoxaban Impurity 1 chemically represented as 5-nitroso-4,5,6,7- tetrahydrothiazolo[5,4-c] pyridin-2-amine.Synchemia is the leading manufacturing and exporter of N-Nitroso Edoxaban Impurity 1 .We supply N-Nitroso Edoxaban Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143636 |
| CAS No | NA |
| Mol.F. | C5D12N2O |
| Mol.Wt. | 128.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143637 |
| CAS No | NA |
| Mol.F. | C6H2D4F3N5O |
| Mol.Wt. | 225.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143638 |
| CAS No | NA |
| Mol.F. | C13H18N4O5S |
| Mol.Wt. | 342.4 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143639 |
| CAS No | NA |
| Mol.F. | C18H18N2O2 |
| Mol.Wt. | 294.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143640 |
| CAS No | NA |
| Mol.F. | C7H12N2O5 |
| Mol.Wt. | 204.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143641 |
| CAS No | NA |
| Mol.F. | C11H21N3O5 |
| Mol.Wt. | 275.31 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143642 |
| CAS No | NA |
| Mol.F. | C24H27F3N4O4 |
| Mol.Wt. | 492.50 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143643 |
| CAS No | NA |
| Mol.F. | C11H14N4O2 |
| Mol.Wt. | 234.26 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143644 |
| CAS No | NA |
| Mol.F. | C18H15F3N4O3 |
| Mol.Wt. | 392.33 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143645 |
| CAS No | NA |
| Mol.F. | C11H16N2O3 |
| Mol.Wt. | 192.26 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143646 |
| CAS No | NA |
| Mol.F. | C27H29N5O2 |
| Mol.Wt. | 455.56 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143647 |
| CAS No | NA |
| Mol.F. | C2729N5O3 |
| Mol.Wt. | 471.56 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143648 |
| CAS No | NA |
| Mol.F. | C14H19N5O2 |
| Mol.Wt. | 289.3 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143649 |
| CAS No | NA |
| Mol.F. | C28H23ClN4O6 |
| Mol.Wt. | 547 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143650 |
| CAS No | NA |
| Mol.F. | C9H11N7OS |
| Mol.Wt. | 265.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143651 |
| CAS No | NA |
| Mol.F. | C5H9N3O2 |
| Mol.Wt. | 143.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |